REFERENCES
- Ayd, F. J. (1961). A survey of drug-induced extrapyramidal reactions. Journal of American Medical Association, 175(12), 1054–1060.
- Evidente, V. G. (2002). Zolpidem improves dystonia in “Lubag” or X-linked dystonia- parkinsonism syndrome. Neurology, 58, 662–663.
- Fahn, S. (1979). Treatment of dystonia with high dosage anticholinergic medication. Neurology, 29, 605.
- Gordon, M. F., Diaz-Olivo, R., Hunt, A. L., & Fahn, S. (1993). Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders. Movement Disorders, 8(4), 484–488.
- Greene, P., Shale, H., & Fahn, S. (1988). Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Movement Disorders, 3(1), 46–60.
- Horn, S., & Comella, C. L. (2004). Pharmacologic treatment of generalized dystonia. In M. F. Brin, C. L. Comella & J. Jankovic (eds), Dystonia: Etiology, Clinical Features, and Treatment. Philadephia, PA: Lippincott Williams & Wilkins, 71–77.
- Jankovic, J., & Beach, J. (1997). Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology, 48, 358–362.
- Karp, B. I., Goldstein, S. R., Chen, R., Samii, A., Bara-Jimenez, W., & Hallet, M. (1999). An open trial of clozapine for dystonia. Movement Disorders, 14(4), 652–657.
- Lee, L. V., Munoz, E. L., Tan, K. T., & Reyes, M. T. (2001). Sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Molecular Pathology, 54(6), 362–368.
- Lee, L. V., Pascasio, F. M., Fuentes, F. D., & Viterbo, G. H. (1976). Torsion dystonia in Panay, Philippines. Advances in Neurology, 14, 137–151.
- Teravainen, H., Calne, S., Burton, K., Beckman, J., & Calne, D. B. (1988). Efficacy of dopamine agonists in dystonia. Advances in Neurology, 50, 571–577.